1 0

    FDA RECORDS CONTAINING “CHILD” OR “MINOR” AND PUBERTY BLOCKERS OR GNRH ANALOGUES

    FDA RECORDS CONTAINING “CHILD” OR “MINOR” AND PUBERTY BLOCKERS OR GNRH ANALOGUES

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: Cavezzoi, Kehoe, etc - All records containing the terms, “child” or “minor” and “Lupron,” “Leuprorelin,” “Fensolvi,” “Synarel,” “Nafarelin,” “Supprelin,” “Vantas,” “Triptodur”, “Histrelin,” “puberty blocker,” “GnRH agonist,” or “GnRH analogues.”
    Tags: Pharma, Adverse Event, 2022
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details